Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00265993
Status:
COMPLETED
Last Update Posted:
2010-02-03
First Post:
2005-12-14
Brief Title:
Enoxaparin in Acute Venous Thromboembolic Disease
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
The Efficacy of Subcutaneous Enoxaparin Once Daily in the Treatment of Acute Venous Thromboembolic Disease an Open-labelled Non-comparative Multicentric Phase IV Trial
Status:
COMPLETED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study objectives
To evaluate the efficacysafety profile of enoxaparin once a day treatment in acute venous thromboembolic disease
To evaluate the efficacysafety profile of enoxaparin once a day treatment in acute venous thromboembolic disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None